Crinetics Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -6.02M-9.11M-26.96M-50.37M-73.96M-107.55M-163.56M-209.17M-297.42M
Depreciation and Depletion 0.50M0.90M0.90M0.90M1.00M1.10M2.80M
Share-based Compensation 0.27M0.27M2.32M6.29M10.43M17.35M28.27M40.94M69.39M
Gains from Investment Securities 0.84M2.34M3.13M4421.53M6553.59M9.76M12.63M13.67M
Non-cash Items 0.25M1.24M1.96M80.91M4122.61M5.26M6.48M
Cash from Operations -5.47M-9.48M-19.46M-46.38M-62.03M-88.59M-115.20M-166.31M-225.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.43M1.23M0.23M-0.42M-0.03M6.27M14.93M
Depreciation & Amortization (CF) 0.09M0.13M0.47M0.89M0.95M0.92M0.98M1.10M2.79M
Change in Working Capital
Change in Accured Expenses 0.30M0.05M7.36M0.70M2.72M6.29M10.99M14.65M17.54M
Investing Activities
Capital Expenditures 0.19M0.30M1.06M0.49M0.19M0.44M1.66M4.69M3.84M
Change in Acquisitions & Divestments 150.29M136.00M69.36M157.49M337.13M575.80M
Cash from Investing Activities -0.19M-0.30M-119.46M41.67M0.22M-56.48M-173.98M-200.41M-574.82M
Financing Activities
Other financing activities 0.03M
Change in Capital Stock
Shares Issued 0.07M106.47M0.13M114.28M249.54M117.24M369.02M970.05M
Preferred Shares Issued -0.01M11.97M63.27M
Misc.
Cash from Financing Activities -0.05M11.82M170.20M0.07M114.57M252.68M121.96M388.94M1010.43M
Change in Cash -5.71M2.04M31.28M-4.65M52.76M107.61M-167.22M22.22M209.65M
Free Cash Flow -5.66M-9.78M-20.52M-46.87M-62.21M-89.02M-116.86M-171.00M-229.81M
Net Cash Flow -5.71M2.04M31.28M-4.65M52.76M107.61M-167.22M22.22M209.65M